Live Breaking News & Updates on Clear Trial

Stay updated with breaking news from Clear trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CLEAR Trial: Lenvatinib plus Pembrolizumab in Advanced RCC

Experts highlight key clinical updates from the CLEAR trial presented at the 2023 IKCS: North America congress, assessing lenvatinib plus pembrolizumab in patients with advanced RCC. ....

United States , Surrounding Meetings , North America , Renal Cell Carcinoma , Advanced Renal Cell Carcinoma , Advanced Rcc , Renal Cell Carcinoma Treatments , Rcc Treatments , Clear Trial , Clear Study , Advanced Rcc Treatment , Advanced Renal Cell Carcinoma Treatment ,

Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma. ....

Advanced Kidney Cancer Treatment Landscape , Kidney Cancer , Renal Cell Carcinoma , Kidney Cancer Studies , Kidney Cancer Trials , Clear Trial , Keynote 426 , Checkmate 9er ,

Patient Profile: A 67-Year-Old Man With Metastatic Clear Cell RCC

Benjamin Garmezy, MD, presents the case of a 67-year-old man diagnosed with advanced renal cell carcinoma. ....

Pedro Barata , Benjamin Garmezy , Renal Cell Carcinoma , Metastatic Clear Cell Rcc , Imdc Intermediate Risk , Imdc Risk Score , Doublet Immunotherapy , Io Tkis , Clear Trial ,

Front Line Trials in Advanced RCC

Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC. ....

Benjamin Garmezy , Pedro Barata , Renal Cell Carcinoma , Clear Trial , Checkmate 9er , Keynote 426 , Checkmate 214 , Io Tkis ,